Articles

GOP presidential nominee Donald Trump supports Schedule III classification for cannabis, which has already been proposed by the Biden administration.

Boeing’s stock was headed for a nice bounce Monday, as the tentative agreement reached with the International Association of Machinists District 751 removed one of the headwinds the aerospace giant has been facing.

With more Nvidia earnings growth ahead, Citi says the company should still help the S&P 500’s performance, though potentially not to the same extent as before.

JPMorgan now favors small caps over large caps, and no longer likes growth over value

“Interest rates are going down so CDs might not be an option for long.”

Shares of Summit Therapeutics Inc. jumped more than 30% premarket on Monday after the biotech company released late-stage trial data showing that its experimental lung-cancer treatment topped Merck’s blockbuster Keytruda.

The transaction marks an example of efforts by financial firms to reposition their balance sheets with higher-yielding assets as interest rates have risen.

Elon Musk’s SpaceX is targeting Tuesday for the launch of the historic Polaris Dawn mission but warned that weather conditions are only 40% favorable for the launch, which has already been delayed once.

Squarespace’s stock climbed toward a three-year high in premarket trades Monday, after private-equity firm Permira raised its buyout bid for the online brand-building platform.

MBX joins the IPO pipeline just days after two other biotechs set terms for their planned deals.

CEO Tim Cook has been an admirable leader for Apple, but he’s no Steve Jobs.

Former European Central Bank President and Italian prime minister Mario Draghi on Monday laid out the case for a massive series of investments to boost the region’s stagnant economy.